Welcome to the latest edition of our UK Competition Law Newsletter – a monthly briefing on developments in UK antitrust law, enforcement, and practice.
Highlights include:
CAT quashes the CMA’s record antitrust fine in Pfizer/Flynn, finding that the CMA misapplied
the legal test for excessive pricing.
CMA shines spotlight on digital platforms, conducting several Phase 2 reviews and considering
further work in digital advertising.
UK competition regime prepares for Brexit, despite significant uncertainty about how, when, or
if it will occur.
